332 related articles for article (PubMed ID: 9258263)
1. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.
Sze CI; Troncoso JC; Kawas C; Mouton P; Price DL; Martin LJ
J Neuropathol Exp Neurol; 1997 Aug; 56(8):933-44. PubMed ID: 9258263
[TBL] [Abstract][Full Text] [Related]
2. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains.
Sze CI; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ
J Neurol Sci; 2000 Apr; 175(2):81-90. PubMed ID: 10831767
[TBL] [Abstract][Full Text] [Related]
3. N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease.
Sze C; Bi H; Kleinschmidt-DeMasters BK; Filley CM; Martin LJ
J Neurol Sci; 2001 Jan; 182(2):151-9. PubMed ID: 11137521
[TBL] [Abstract][Full Text] [Related]
4. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
[TBL] [Abstract][Full Text] [Related]
6. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging.
Brown DF; Risser RC; Bigio EH; Tripp P; Stiegler A; Welch E; Eagan KP; Hladik CL; White CL
J Neuropathol Exp Neurol; 1998 Oct; 57(10):955-60. PubMed ID: 9786245
[TBL] [Abstract][Full Text] [Related]
7. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
8. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
Minger SL; Honer WG; Esiri MM; McDonald B; Keene J; Nicoll JA; Carter J; Hope T; Francis PT
J Neuropathol Exp Neurol; 2001 Oct; 60(10):929-36. PubMed ID: 11589423
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.
Scheff SW; Ansari MA; Mufson EJ
Neurobiol Aging; 2016 Jun; 42():1-12. PubMed ID: 27143416
[TBL] [Abstract][Full Text] [Related]
11. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.
Reddy PH; Mani G; Park BS; Jacques J; Murdoch G; Whetsell W; Kaye J; Manczak M
J Alzheimers Dis; 2005 Apr; 7(2):103-17; discussion 173-80. PubMed ID: 15851848
[TBL] [Abstract][Full Text] [Related]
12. Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis.
Bigio EH; Hynan LS; Sontag E; Satumtira S; White CL
Neuropathol Appl Neurobiol; 2002 Jun; 28(3):218-27. PubMed ID: 12060346
[TBL] [Abstract][Full Text] [Related]
13. Correlations of synaptic and pathological markers with cognition of the elderly.
Dickson DW; Crystal HA; Bevona C; Honer W; Vincent I; Davies P
Neurobiol Aging; 1995; 16(3):285-98; discussion 298-304. PubMed ID: 7566338
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.
Tarawneh R; D'Angelo G; Crimmins D; Herries E; Griest T; Fagan AM; Zipfel GJ; Ladenson JH; Morris JC; Holtzman DM
JAMA Neurol; 2016 May; 73(5):561-71. PubMed ID: 27018940
[TBL] [Abstract][Full Text] [Related]
15. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
Sabbagh MN; Reid RT; Corey-Bloom J; Rao TS; Hansen LA; Alford M; Masliah E; Adem A; Lloyd GK; Thal LJ
J Neural Transm (Vienna); 1998; 105(6-7):709-17. PubMed ID: 9826113
[TBL] [Abstract][Full Text] [Related]
16. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.
Scheff SW; Price DA; Ansari MA; Roberts KN; Schmitt FA; Ikonomovic MD; Mufson EJ
J Alzheimers Dis; 2015; 43(3):1073-90. PubMed ID: 25147118
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.
Gosche KM; Mortimer JA; Smith CD; Markesbery WR; Snowdon DA
Neurology; 2002 May; 58(10):1476-82. PubMed ID: 12034782
[TBL] [Abstract][Full Text] [Related]
18. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
19. Pathological correlates of cognitive decline in Alzheimer's disease.
Thind K; Sabbagh MN
Panminerva Med; 2007 Dec; 49(4):191-5. PubMed ID: 18091671
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
Truchot L; Costes SN; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Croisile B; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
Neurology; 2007 Sep; 69(10):1012-7. PubMed ID: 17785670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
